Yapeng Lin
Overview
Explore the profile of Yapeng Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu R, Chen C, Liu F, Lin Y, Chu H, Liu H, et al.
Cerebrovasc Dis
. 2024 Sep;
:1-7.
PMID: 39236681
Introduction: The fourth INTEnsive ambulance-delivered blood pressure Reduction in hyper-ACute stroke Trial (INTERACT4) is a large-scale, multicenter, prospective, randomized, open-label, blinded endpoint assessment trial, initiated in an ambulance in China,...
2.
He S, Tan Q, Shao H, Mao F, Leng X, Liu W, et al.
Cerebrovasc Dis
. 2024 Jul;
:1-11.
PMID: 38964297
Introduction: The effectiveness of thromboelastography (TEG)-guided antiplatelet therapy in patients with ischemic cerebrocardiovascular diseases is not well-established. This systematic review evaluates the efficacy and safety of TEG-guided antiplatelet therapy compared...
3.
Billot L, Chen C, Song L, Lin Y, Liu F, Chen X, et al.
Cerebrovasc Dis
. 2024 May;
:1-4.
PMID: 38815572
Introduction: Recruitment is complete in the fourth INTEnsive ambulance-delivered blood pressure Reduction in hyper-ACute stroke Trial (INTERACT4), a multicenter, prospective, randomized, open-label, blinded endpoint assessed trial of prehospital blood pressure...
4.
Li G, Lin Y, Yang J, Anderson C, Chen C, Liu F, et al.
N Engl J Med
. 2024 May;
390(20):1862-1872.
PMID: 38752650
Background: Treatment of acute stroke, before a distinction can be made between ischemic and hemorrhagic types, is challenging. Whether very early blood-pressure control in the ambulance improves outcomes among patients...
5.
Chen K, Cheng X, Yuan S, Sun Y, Hao J, Tan Q, et al.
Mol Genet Genomics
. 2024 May;
299(1):50.
PMID: 38734849
Intracerebral hemorrhage (ICH) is one of the major causes of death and disability, and hypertensive ICH (HICH) is the most common type of ICH. Currently, the outcomes of HICH patients...
6.
Chen K, Chi Y, Cheng H, Yang M, Tan Q, Hao J, et al.
J Cell Mol Med
. 2024 Mar;
28(7):e18210.
PMID: 38506071
Extrachromosomal circular DNA (eccDNA) is a new biomarker and regulator of diseases. However, the role of eccDNAs in large-artery atherosclerotic (LAA) stroke remains unclear. Through high-throughput circle-sequencing technique, the length...
7.
Lin Y, Jiang C, Pan Y, Xu Z
Front Psychol
. 2024 Mar;
15:1346326.
PMID: 38476383
This study delves into the effects of mindfulness on workplace spirituality, work-life balance, and perceived professional benefits among nurses operating in the high-pressure environments of hospitals in Jiangxi Province, China....
8.
Tan Q, Yang L, Yuan S, Zheng D, Lin Y, Chen K, et al.
Open Med (Wars)
. 2024 Mar;
19(1):20240899.
PMID: 38463525
Background: N6-methyladenosine (mA) is the most frequently occurring interior modification in eukaryotic messenger RNA (mRNA), and abnormal mRNA modifications can affect many biological processes. However, mA's effect on the metabolism...
9.
Chen C, Lin Y, Liu F, Chen X, Billot L, Li Q, et al.
Trials
. 2023 Dec;
24(1):817.
PMID: 38124205
Background And Aims: Uncertainty persists over the effects of blood pressure (BP) lowering in acute stroke. The INTEnsive ambulance-delivered blood pressure Reduction in hyper-Acute stroke Trial (INTERACT4) aims to determine...
10.
Lin Y, Liu Y, Liu L, Zhang L, Lin Y, Yu J, et al.
Medicine (Baltimore)
. 2023 Nov;
102(46):e36072.
PMID: 37986382
Background: Recent studies have highlighted the unfavorable prognosis of patients with spontaneous intracerebral hemorrhage (ICH) who have received prior antiplatelet therapy (PAP). Platelet infusion therapy (PIT) is commonly administered to...